Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravaginal DHEA for Vaginal Atrophy (ERC-234)
NCT01358760Phase 3Completed
- Sponsor
- Endoceutics
- Start
- Jun 2011
- Primary completion
- Apr 2012
- Modality
- Allosteric Modulators
- Countries
- 2
01
Overview
A Phase 3 trial of prasterone in vaginal atrophy, sponsored by Endoceutics. Started Jun 2011; status: completed.
02
Drugs
prasterone
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT01358760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01358760.